Morgan Angharad R, Fraser Alan G, Ferguson Lynnette R
Discipline of Nutrition, FMHS, The University of Auckland, Auckland, New Zealand.
J Negat Results Biomed. 2012 Jan 28;11:8. doi: 10.1186/1477-5751-11-8.
Metallothioneins (MTs) are excellent candidate genes for Inflammatory Bowel Disease (IBD) and have previously been shown to have altered expression in both animal and human studies of IBD. This is the first study to examine genetic variants within the MT genes and aims to determine whether such genetic variants have an important role in this disease. 28 tag SNPs in genes MT1 (subtypes A, B, E, F, G, H, M, X), MT2, MT3 and MT4 were selected for genotyping in a well-characterized New Zealand dataset consisting of 406 patients with Crohn's Disease and 638 controls. We did not find any evidence of association for MT genetic variation with CD. The lack of association indicates that genetic variants in the MT genes do not play a significant role in predisposing to CD in the New Zealand population.
金属硫蛋白(MTs)是炎症性肠病(IBD)的优秀候选基因,此前在IBD的动物和人体研究中均显示其表达发生了改变。这是第一项研究MT基因内的遗传变异的研究,旨在确定此类遗传变异在该疾病中是否起重要作用。在一个特征明确的新西兰数据集中,对MT1(亚型A、B、E、F、G、H、M、X)、MT2、MT3和MT4基因中的28个标签单核苷酸多态性(tag SNPs)进行基因分型,该数据集包括406例克罗恩病患者和638名对照。我们没有发现MT基因变异与克罗恩病相关的任何证据。缺乏相关性表明,在新西兰人群中,MT基因的遗传变异在克罗恩病易感性方面不起重要作用。